MRK
Merck's second quarter revenue of $16.6B beat estimates, driven by strong Keytruda sales and an upgraded FY2026 outlook.
Merck reported second quarter 2026 revenue of $16.6 billion, a 5% year-over-year increase that surpassed analyst expectations. The company posted a non-GAAP...
